Detail Information of Microbiota Influence
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0008 Transporter Info | ||||
Gene Name | SLCO1B1 | ||||
Transporter Name | Organic anion transporting polypeptide 1B1 | ||||
Gene ID | |||||
UniProt ID | |||||
Microbiota Influence of This DT (MBI) | |||||
---|---|---|---|---|---|
Bacteria: Host unspecified microbiota |
|||||
Genus: Unknown microbiota |
|||||
Host unspecified microbiota |
Click to Show/Hide the Full List 7 Microbe Influence Related to This Species |
||||
Microbe Influence 1 |
Up regulating of SLCO1B1 expression in the health condition | [1] , [2] | |||
Regulating Factor |
|||||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Studied Tissue |
Liver | ||||
In Vivo Model |
IQI mice | ||||
Detailed Description |
The metabolite lithocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B1. | ||||
Microbe Influence 2 |
Up regulating of SLCO1B1 expression in the health condition | [1] , [3] | |||
Regulating Factor |
|||||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Studied Tissue |
Liver | ||||
In Vivo Model |
PXR mice | ||||
In Vitro Model |
Mouse embryo embryonic stem cells (ES-R1) | ||||
Detailed Description |
The metabolite dehydrolithocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B1. | ||||
Microbe Influence 3 |
Up regulating of SLCO1B1 expression in the health condition | [4] | |||
Regulating Factor |
|||||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Studied Tissue |
Liver | ||||
Detailed Description |
The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B1. | ||||
Microbe Influence 4 |
Up regulating of SLCO1B1 expression in the health condition | [4] | |||
Regulating Factor |
|||||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Studied Tissue |
Liver | ||||
Detailed Description |
The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B1. | ||||
Microbe Influence 5 |
Up regulating of SLCO1B1 expression in the health condition | [4] | |||
Regulating Factor |
|||||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Studied Tissue |
Liver | ||||
Detailed Description |
The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B1. | ||||
Microbe Influence 6 |
Up regulating of SLCO1B1 expression in the health condition | [4] | |||
Regulating Factor |
|||||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Studied Tissue |
Liver | ||||
Detailed Description |
The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B1. | ||||
Microbe Influence 7 |
Up regulating of SLCO1B1 expression in the health condition | [4] | |||
Regulating Factor |
|||||
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
Studied Tissue |
Liver | ||||
Detailed Description |
The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B1. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.